Acreage Holdings 과거 수익 실적

과거 기준 확인 0/6

Acreage Holdings은 연평균 20.8%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 43.4%의 비율로 수입이 증가했습니다. 매출은 연평균 19.4%의 비율로 증가했습니다.

주요 정보

20.8%

수익 성장률

27.0%

EPS 성장률

Pharmaceuticals 산업 성장	23.1%
매출 성장률	19.4%
자기자본 수익률	n/a
순이익	-56.2%
최근 수익 업데이트	30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Investors Continue Waiting On Sidelines For Acreage Holdings, Inc. (CSE:ACRG.A.U)

Sep 24

Acreage Holdings, Inc. (CSE:ACRG.A.U) Stock Rockets 44% But Many Are Still Ignoring The Company

Sep 07

Investors Still Aren't Entirely Convinced By Acreage Holdings, Inc.'s (CSE:ACRG.A.U) Revenues Despite 44% Price Jump

Sep 07

Acreage Holdings, Inc. (CSE:ACRG.A.U) Just Reported, And Analysts Assigned A US$1.50 Price Target

Aug 10

수익 및 비용 분석

Acreage Holdings 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

CNSX:ACRG.A.U 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용
30 Sep 24	177	-99	80
30 Jun 24	194	-87	83
31 Mar 24	213	-82	83
31 Dec 23	223	-69	87
30 Sep 23	228	-133	96
30 Jun 23	233	-148	102
31 Mar 23	236	-142	105
31 Dec 22	237	-140	107
30 Sep 22	238	-85	106
30 Jun 22	224	-75	101
31 Mar 22	207	-68	101
31 Dec 21	189	-63	99
30 Sep 21	162	-60	122
30 Jun 21	146	-88	131
31 Mar 21	129	-122	148
31 Dec 20	115	-287	186
30 Sep 20	104	-300	197
30 Jun 20	95	-298	218
31 Mar 20	85	-299	228
31 Dec 19	74	-150	201
30 Sep 19	63	-125	163
30 Jun 19	47	-99	124
31 Mar 19	32	-47	78
31 Dec 18	21	-27	47
30 Sep 18	13	-8	31
30 Jun 18	9	3	17
31 Mar 18	8	-11	13
31 Dec 17	8	-9	10
31 Dec 16	4	-2	3

양질의 수익: ACRG.A.U 은(는) 현재 수익성이 없습니다.

이익 마진 증가: ACRG.A.U 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: ACRG.A.U 은(는) 수익성이 없지만 지난 5년 동안 연간 20.8% 의 비율로 손실을 줄였습니다.

성장 가속화: 현재 수익성이 없기 때문에 ACRG.A.U 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: ACRG.A.U 은(는) 수익성이 없어 지난 해 수익 성장을 Pharmaceuticals 업계( -51.1% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: ACRG.A.U 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

Acreage Holdings 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Third quarter 2024 earnings released: US$0.16 loss per share (vs US$0.067 loss in 3Q 2023)

Acreage Holdings, Inc. to Report Q3, 2024 Results on Nov 14, 2024

Second quarter 2024 earnings released: US$0.18 loss per share (vs US$0.14 loss in 2Q 2023)

Full year 2022 earnings released: US$1.28 loss per share (vs US$0.60 loss in FY 2021)

Acreage Holdings, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022

Third quarter 2022 earnings released: US$0.20 loss per share (vs US$0.11 loss in 3Q 2021)

Recent updates

Third quarter 2024 earnings released: US$0.16 loss per share (vs US$0.067 loss in 3Q 2023)

Acreage Holdings, Inc. to Report Q3, 2024 Results on Nov 14, 2024

New minor risk - Shareholder dilution

Investors Continue Waiting On Sidelines For Acreage Holdings, Inc. (CSE:ACRG.A.U)

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: US$0.18 loss per share (vs US$0.14 loss in 2Q 2023)

No longer forecast to breakeven

Acreage Holdings, Inc. Commences Non-Medical Cannabis Sales in Ohio

Acreage Holdings, Inc. Appoints Rebecca Kirk as Chief Operating Officer, Effective July 1, 2024

Acreage Holdings, Inc. announced that it has received $9.99996 million in funding

Acreage Holdings, Inc. announced that it expects to receive $9.99996 million in funding

Acreage Holdings, Inc. announced delayed 10-Q filing

Acreage Holdings, Inc. announced delayed annual 10-K filing

Acreage Holdings, Inc., Annual General Meeting, Jun 06, 2024

Acreage Holdings, Inc. Celebrates Launch of Adult-Use Sales at Vernon, Connecticut Dispensary

Acreage Broadens Footprint with Relocation of Third Dispensary in Connecticut

Acreage Holdings, Inc. Launches the Botanist Gummies in New York and Provides Core Market Update

Acreage Holdings, Inc. Announces CFO Changes, Effective December 31, 2023

Acreage Holdings, Inc. announced delayed 10-Q filing

New minor risk - Shareholder dilution

Acreage Holdings, Inc. (CSE:ACRG.A.U) Stock Rockets 44% But Many Are Still Ignoring The Company

Investors Still Aren't Entirely Convinced By Acreage Holdings, Inc.'s (CSE:ACRG.A.U) Revenues Despite 44% Price Jump

Less than half of directors are independent

Acreage Holdings, Inc Appoints Carl Nesbitt as Chief Financial Officer, Effective July 3, 2023

Acreage Holdings, Inc. Announces Board Changes

Acreage Holdings, Inc. Announces Chief Executive Officer Changes

Acreage Holdings, Inc. announced delayed 10-Q filing

Acreage Holdings, Inc. Announces Resignation of Steve Goertz as Chief Financial Officer, Effective June 15, 2023

Full year 2022 earnings released: US$1.28 loss per share (vs US$0.60 loss in FY 2021)

Acreage Holdings, Inc. Introduces Fast-Acting Gummies to the Botanist Offerings

Acreage Holdings, Inc., Annual General Meeting, Jan 25, 2023

Forecast breakeven date pushed back to 2024

Forecast breakeven date pushed back to 2024

Forecast to breakeven in 2023

Acreage Holdings, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022

Third quarter 2022 earnings released: US$0.20 loss per share (vs US$0.11 loss in 3Q 2021)

Acreage Holdings, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Acreage Holdings, Inc. (CSE:ACRG.A.U) Just Reported, And Analysts Assigned A US$1.50 Price Target

Acreage Holdings, Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Acreage Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Independent Director recently bought US$174k worth of stock

First quarter 2022 earnings: EPS and revenues miss analyst expectations

An unknown buyer completed the acquisition of a dispensary and cultivation facility in Oregon from Acreage Holdings, Inc. (CNSX:ACRG.A.U) for $2 million.

Price target decreased to US$2.80

Less than half of directors are independent

Acreage Holdings, Inc. Appoints Corey Sheahan as General Counsel

CEO & Director recently sold US$51k worth of stock

Consensus forecasts updated

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Acreage Holdings, Inc. Appoints Steve Strom to the Board of Directors

Acreage Holdings, Inc. Appoints Chief Operating Officer and Announces Senior Leadership Update

Acreage Holdings, Inc. to Report Q4, 2021 Results on Mar 10, 2022

Forecast to breakeven in 2023

Acreage Revamps House of Brands with Launch of Craft Brand Superflux and Expansion of The Botanist Product Line

Chief Operating Officer exercised options to buy US$5.6k worth of stock.

Third quarter 2021 earnings released

Consensus forecasts updated

Founder & Chairman recently bought US$77k worth of stock

Second quarter 2021 earnings released: US$0.023 loss per share (vs US$0.38 loss in 2Q 2020)

Founder & Chairman exercised options to buy US$619k worth of stock.

First quarter 2021 earnings released

Chief Financial Officer has left the company

Full year 2020 earnings released: US$2.87 loss per share (vs US$1.74 loss in FY 2019)

Chief Operating Officer recently sold US$250k worth of stock

Chief Operating Officer exercised options and sold US$200k worth of stock

Full year 2020 earnings released: US$2.87 loss per share (vs US$1.74 loss in FY 2019)

Earnings beat expectations, revenue disappoints